Synthetic and natural iron chelators: Therapeutic potential and clinical use

Cites (250)

Items 201–250 of 250

1. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
   Norbert Gattermann · 2007 · Leukemia Research
2. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator
   Rong Zhao, Roy P. Planalp, Rong Ma, Bryan T. Greene, Bradley Todd Jones, Martin W. Brechbiel, Frank M. Torti, Suzy V. Torti · 2004 · Biochemical Pharmacology
3. The flavonoid quercetin induces hypoxia-inducible factor-1α (HIF-1α) and inhibits cell proliferation by depleting intracellular iron
   Anastasia Triantafyllou, Panagiotis Liakos, Andreas K. Tsakalof, Georgia Chachami, Efrosyni Paraskeva, Pashalis-Adam Molyvdas, Elena Georgatsou, George Simos, Sophia Bonanou · 2006 · Free Radical Research
4. Zinc supplementation decreases the development of atherosclerosis in rabbits
   Minqin Ren, Reshmi Rajendran, Pan Ning, Benny Tan Kwong Huat, Ong Choon Nam, F. Watt, Andrew M. Jenner, Barry B. Halliwell · 2006 · Free Radical Biology and Medicine
5. Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
   Xi Yuan, Wei Li · 2008 · Current Medicinal Chemistry
6. The Metabolites of the Cardioprotective Drug Dexrazoxane Do Not Protect Myocytes from Doxorubicin-Induced Cytotoxicity
   Brian B. Hasinoff, Patricia E. Schroeder, Daywin Patel · 2003 · Molecular Pharmacology
7. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.
   Odysseas Platis, Georgios K. Anagnostopoulos, Kallisteni Farmaki, Markos Posantzis, Efstathios D. Gotsis, Georgios Tolis · 2004 · PubMed
8. Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
   Karen W L Yee, Jörge E. Cortes, Alessandra Ferrajoli, Guillermo Garcia‐Manero, Srđan Verstovšek, William G. Wierda, Deborah Ann Thomas, Stefan H Faderl, Ivan King, Susan Mary O'Brien et al. · 2006 · Leukemia Research
9. Transfusion and Exchange Transfusion in Sickle Cell Anaemias, with Particular Reference to Iron Metabolism
   John B. Porter, E. R. Huehns · 2009 · Acta Haematologica
10. Coronary Microvascular Adaptation to Myocardial Metabolic Demand Can Be Restored by Inhibition of Iron-Catalyzed Formation of Oxygen Free Radicals in Type 2 Diabetic Patients
    Alain Nitenberg, Séverine Ledoux, Paul Elie Valensi, R. N. Sachs, Isabelle Antony · 2002 · Diabetes
11. Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women,,,
    James H. Swain, D. Lee Alekel, Sarah B. Dent, Charles T. Peterson, Manju B. Reddy · 2002 · American Journal of Clinical Nutrition
12. Effects of red grape skin and seed extract supplementation on atherosclerosis in Watanabe heritable hyperlipidemic rabbits
    Hanne Winther Frederiksen, Alicja Mortensen, Malene Schrøder, Henrik Lauritz Frandsen, Anette Bysted, Pia Knuthsen, Salka Elbøl Rasmussen · 2007 · Molecular Nutrition & Food Research
13. Desferrioxamine Inhibits Production of Cytotoxic Heme to Protein Cross-Linked Myoglobin: A Mechanism to Protect against Oxidative Stress without Iron Chelation
    Brandon J. Reeder, Michael T. Wilson · 2005 · Chemical Research in Toxicology
14. A novel protein–mineral interface
    Dmitry G. Alexeev, Haizhong Zhu, Maolin Guo, Weiqing Zhong, Dominic J. B. Hunter, Weiping Yang, Dominic J. Campopiano, Peter John Sadler · 2003 · Nature Structural & Molecular Biology
15. Physicochemical study of floranol, its copper(II) and iron(III) complexes, and their inhibitory effect on LDL oxidation
    Françoise Vasconcelos Botelho, Jacqueline Isaura Alvarez-Leite, Virginia Soares Lemos, Adriano M.C. Pimenta, Hállen D. R. Calado, Túlio Matencio, C.T. Miranda, Elene Cristina Pereira-Maia · 2007 · Journal of Inorganic Biochemistry
16. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits
    Tomáš Šimůnek, Ivona Klimtová, J. Kaplanová, Martin Štěrba, Y Mazurová, Michaela Adamcová, Radomír Hrdina, Vladimír Geršl, Přemysl Poňka · 2004 · Pharmacological Research
17. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2
    Hiroshi Kawabata, Xiangjun Tong, Takafumi Kawanami, Yuji Wano, Yuko Hirose, Susumu Sugai, Harold Phillip Koeffler · 2004 · British Journal of Haematology
18. Oxo-iron clusters in a bacterial iron-trafficking protein: new roles for a conserved motif
    Haizhong Zhu, Dmitry G. Alexeev, Dominic J. B. Hunter, Dominic J. Campopiano, Peter John Sadler · 2003 · Biochemical Journal
19. Prolonged Exposure to LPS Increases Iron, Heme, and p22 phox Levels and NADPH Oxidase Activity in Human Aortic Endothelial Cells
    Lixin Li, Balz B. Frei · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
20. Soy Protein Influences the Development of the Metabolic Syndrome in Male Obese ZDFxSHHF Rats
    Jeremy E. Davis, Muhammad Javed Iqbal, Jena J. Steinle, J. Oitker, D. Allan Higginbotham, Richard G. Peterson, William J. Banz · 2005 · Hormone and Metabolic Research
21. Therapeutic Potential of Iron Chelators in Cancer Therapy
    Richardson, Des R. · 2002 · Advances in Experimental Medicine and Biology
22. Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents
    Pahl, Paula M. B., Horwitz, Lawrence D. · 2005 · Cancer Investigation
23. Iron chelation, quo vadis?
    Hanspeter Nick · 2007 · Current Opinion in Chemical Biology
24. Soy protein isoflavones, lipids and arterial disease
    Mara Z. Vitolins, Mary S. Anthony, Gregory L. Burke · 2001 · Current Opinion in Lipidology
25. In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone)
    Christopher Andrew Barker, William E. Burgan, Donna J. Carter, David Cerna, David R. Gius, Melinda G. Hollingshead, Kevin A. Camphausen, Philip J. Tofilon · 2006 · Clinical Cancer Research
26. Dexrazoxane (ICRF-187) Protects Cardiac Myocytes Against Hypoxia-Reoxygenation Damage
    Brian B. Hasinoff · 2002 · Cardiovascular Toxicology
27. Evaluation of New Iron Chelators for Clinical Use
    John B. Porter · 2009 · Acta Haematologica
28. Desferrithiocin is a more potent antineoplastic agent than desferrioxamine
    Anthony Kicic, Anita C. G. Chua, Erica Baker · 2002 · British Journal of Pharmacology
29. PCR differential display-based identification of regulator of G protein signaling 10 as the target gene in human colon cancer cells induced by black tea polyphenol theaflavin monogallate
    Jiebo Lu, Alexander Gosslau, Alice Y.‐C. Liu, Kuang Yu Chen · 2008 · European Journal of Pharmacology
30. Efficacy of Curcuminoids in Alleviation of Iron Overload and Lipid Peroxidation in Thalassemic Mice
    Thephinlap, C., Phisalaphong, C., Fucharoen, S., Porter, J., Srichairatanakool, S. · 2009 · Medicinal Chemistry
31. Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy
    Athanasios Christoforidis, Vassilios Perifanis, Ioanna Tsatra, Efthymia Vlachaki, Miranda Athanassiou‐Metaxa · 2006 · Diabetes Research and Clinical Practice
32. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy
    Devanur Ld, Robert W. Evans, Patricia Evans, Robert C. Hider · 2007 · Biochemical Journal
33. Synthesis and Potent Antitumor Activities of Novel 1,3,5-cis,cis-Triaminocyclohexane N-Pyridyl Derivatives
    Hyun‐Soon Chong, Suzy V. Torti, Rong Ma, Frank M. Torti, Martin W. Brechbiel · 2004 · Journal of Medicinal Chemistry
34. Optimal Management Strategies for Chronic Iron Overload
    James C. Barton · 2007 · Drugs
35. Short Oxo–Titanium( IV ) Bond in Bacterial Transferrin: A Protein Target for Metalloantibiotics
    Maolin Guo, Ian Harvey, Dominic J. Campopiano, Peter John Sadler · 2006 · Angewandte Chemie International Edition
36. Oral Iron Chelators
    Janet L. Kwiatkowski · 2008 · Pediatric Clinics of North America
37. Black tea polyphenols restrict benzopyrene-induced mouse lung cancer progression through inhibition of Cox-2 and induction of caspase-3 expression.
    Sarmistha Banerjee, Sugata Manna, Sudeshna Mukherjee, Debalina Pal, Chinmay Kr. Panda, Sukta Das · 2006 · PubMed
38. Soy Protein Influences Insulin Sensitivity and Cardiovascular Risk in Male Lean SHHF Rats
    Jeremy E. Davis, Jena J. Steinle, D. Allan Higginbotham, J. Oitker, Richard G. Peterson, William J. Banz · 2005 · Hormone and Metabolic Research
39. Theaflavin Ameliorates Cerebral Ischemia-Reperfusion Injury in Rats Through Its Anti-Inflammatory Effect and Modulation of STAT-1
    Fei Cai, Cairong Li, Jiliang Wu, Jianguo Chen, Chao Liu, Qing Min, Wei Yu, Changhan Ouyang, Jinhe Chen · 2006 · Mediators of Inflammation
40. Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathy
    Eugene H. Herman, Victor J. Ferrans · 1990 · Cancer Treatment Reviews
41. Iron Chelation and Vascular Function: In Search of the Mechanisms
    Ferrara, Dardo E., Taylor, W. Robert · 2005 · Arteriosclerosis, Thrombosis, and Vascular Biology
42. Cranberry Phenolics: Effects on Oxidative Processes, Neuron Cell Death, and Tumor Cell Growth
    Catherine Camaioni Neto, Marva I. Sweeney, Toni L. Lamoureaux, Frankie Solomon, Miwako Kondo, Shawna L. MacKinnon · 2005 · ACS symposium series
43. Free radicals, myocytes and reperfusion injury
    Jeremy J. O. Turner, Catherine A Rice-Evans, Michael J. Davies, Emma Newman · 1990 · Biochemical Society Transactions
44. Combined chelation therapy improves glucose metabolism in patients with β‐thalassaemia major
    Athanasios Christoforidis, Vassilios Perifanis, Miranda Athanassiou‐Metaxa · 2006 · British Journal of Haematology
45. The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents.
    Anthony Kicic, Anita C. G. Chua, Erica Baker · 2002 · PubMed
46. Competing pathways of iron chelation: Angiogenesis or anti‐tumor activity: Targeting different molecules to induce specific effects
    Nghia T.V. Le, Des Raymond Richardson · 2004 · International Journal of Cancer
47. Modulation of cell proliferation and polyamine metabolism in rat liver cell cultures by the iron chelator O-trensox
    François Gaboriau, Cindy Laupen-Chassay, Nicole Pasdeloup, Jean‐Louis Pierre, Pierre Brissot, Gérard Lescoat · 2006 · BioMetals
48. Iron chelator differentially activates macrophage inflammatory protein-3α/CCL20 in immortalized and malignant human oral keratinocytes
    Sun‐Kyung Lee, Jun Lee, Seung‐Ki Min, Dal-Ho Won, You-Mee Lee, Hyun‐Dae Lim, Wan Lee, Hyun‐Ock Pae, Hun‐Taeg Chung, Chang‐Duk Jun et al. · 2008 · Archives of Oral Biology
49. Oral iron chelation therapy with deferiprone in patients with Thalassemia Major.
    Muhammad Raihan Sajid, Farooq Ghani, Salman Naseem Adil, Mohammad Khurshid · 2009 · PubMed
50. Influence of ligand structure on Fe(II) spin-state and redox rate in cytotoxic tripodal chelators
    Matt L. Childers, Joonhyung Cho, Celeste A.S. Regino, Martin W. Brechbiel, Antonio G. DiPasquale, Arnold L. Rheingold, Suzy V. Torti, Frank M. Torti, Roy P. Planalp · 2007 · Journal of Inorganic Biochemistry